openPR Logo
Press release

Postmenopausal Vaginal Atrophy - Pipeline Insight and Therapeutic Assessment Reviewed in 2017

08-10-2017 07:46 AM CET | Health & Medicine

Press release from: Medical Industry Research Reports-[MRH)

MRH

MRH

Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Postmenopausal Vaginal Atrophy-Pipeline Insight, 2017” to its report offerings. The report provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Postmenopausal Vaginal Atrophy.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265520

The report provides comprehensive insights of the ongoing therapeutic research and development across Postmenopausal Vaginal Atrophy. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Postmenopausal Vaginal Atrophy by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope of the report

The report provides a snapshot of the pipeline development for the Postmenopausal Vaginal Atrophy
The report covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Postmenopausal Vaginal Atrophy
The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information
Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Postmenopausal Vaginal Atrophy
The report also covers the dormant and discontinued pipeline projects related to the Postmenopausal Vaginal Atrophy

Reasons to Buy

Establish comprehensive understanding of the pipeline activity across this Postmenopausal Vaginal Atrophy to formulate effective R&D strategies
Gather information of the emerging competitors having potentially lucrative portfolio in this space and create effective counter strategies to gain competitive advantage
Identify the relationship between the drugs and use it for target finding, drug repurposing, and precision medicine
Plot corrective measures for pipeline projects by understanding the pipeline depth and focus of Postmenopausal Vaginal Atrophy therapeutics
Devise in licensing and out licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Modify the therapeutic portfolio by identifying inactive projects and understanding the factors that might have halted their progress

Read Full Report with TOC: http://www.marketresearchhub.com/report/postmenopausal-vaginal-atrophy-pipeline-insight-2017-report.html

Table of Contents:
1. Report Introduction
2. Postmenopausal Vaginal Atrophy Overview
3. Pipeline Therapeutics
An Overview of Pipeline Products for Postmenopausal Vaginal Atrophy
4. Comparative Analysis
5. Products in Clinical Stage
5.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
6.1 Drug Name : Company Name
Product Description
Research and Development
Product Development Activities
7. Therapeutic Assessment
Assessment by Route of Administration
Assessment by Stage and Route of Administration
Assessment by Molecule Type
Assessment by Stage and Molecule Type

Make an Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1265520

About Market Research Hub:
Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.
MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Details:
90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: www.marketresearchhub.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Postmenopausal Vaginal Atrophy - Pipeline Insight and Therapeutic Assessment Reviewed in 2017 here

News-ID: 662850 • Views: 228

More Releases from Medical Industry Research Reports-[MRH)

Global Iris Detector Market, Analysis, Production, Consumption, Trends, Forecast …
To study the market for medical equipments industry  in a precise manner, Market Research Hub (MRH) has included a new research report. The report is titled “Global Iris Detector Market Reports September, 2017”, which enlightens the readers about the market share as well as growth rate during the period 2017-2022 The research study estimates that the medical equipments sector would be rising with a positive CAGR during the same stated
Global Chromium Chelate Supplements Market: Production, Trends, consumption, rev …
Albany, US, 2017-Sep-04 —In this report, the global Chromium Chelate Supplements market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. The report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the
Neurosurgical Products Medical Devices Pipeline Assessment Reviewed in 2017
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Neurosurgical Products - Medical Devices Pipeline Assessment, 2017”, report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase,
Recurrent Head and Neck Cancer Squamous Cell Carcinoma - Pipeline Insight Review …
Market Research Hub (MRH) has recently announced the addition of a fresh report, titled “Recurrent Head And Neck Cancer Squamous Cell Carcinoma-Pipeline Insight, 2017” to its report offerings. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=1265535 The report provides comprehensive insights of the ongoing therapeutic research and development across Recurrent Head And Neck Cancer Squamous Cell

All 5 Releases


More Releases for Postmenopausal

Postmenopausal Osteoporosis Market Share, Trends and Forecast to 2023
The postmenopausal osteoporosis market is expected to grow significantly during the forecast period (2018-2023). Osteoporosis is a skeletal disorder characterized by skeletal fragility, microarchitectural disruption, and low bone mass. It is a condition where the bone density and bone mass decreases and in the long run increases the risk of bone fracture. The global postmenopausal osteoporosis market is significantly growing due to some factors which include increasing geriatric population. Age
Postmenopausal Vaginal Atrophy Drugs Market to Record an Exponential CAGR
According to a new report published by Allied Market Research, titled, "Postmenopausal Vaginal Atrophy Drugs Market by Therapy Type (Estrogen-Based Drugs and Non-Estrogen-Based Drugs) and Drug Forms (Vaginal Gels, Creams, Tablets, Rings, and Patches) - Global Opportunity Analysis and Industry Forecast, 2020-2027". The Global market size of Postmenopausal Vaginal Atrophy Drugs Market was $XX million in 2020 with XX CAGR, and it is expected to reach $XX million by the end
Postmenopausal Osteoporosis Therapeutics Market to Reap Excessive Revenues by 20 …
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The
Postmenopausal Osteoporosis Therapeutics Market Rugged Expansion Foreseen by 202 …
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related
Growth Postmenopausal Osteoporosis Therapeutics Market: 2015 - 2021
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related diseases worldwide and also represents a major public health problem. Osteoporosis is common among females than in the male population. Women with age more than 50 years are more prone to osteoporosis due to hormonal changes occurring after menopause. The